Evaluation of the effect of soybean diet on interferon-α-induced depression in male mice

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 304

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-7-5_006

تاریخ نمایه سازی: 18 تیر 1398

Abstract:

Objective: Interferon-α (IFN) therapy can cause depressive symptom which may lead to drug discontinuation. By interfering with tryptophan pathway, the available level of tryptophan required for serotonin synthesis decreases which could be related to depression. The aim of this study was to evaluate whether soybean diet could improve IFN-induced depression. Materials and Methods: Male mice weighing 28±3 g were used in the forced swimming test (FST) as an animal model of depression; also, locomotor activity was recorded. IFN 16×105 IU/kg was injected subcutaneously for 6 days. Animals were fed with regular diet or soybean diet at 3 concentrations throughout the experiment. Fluoxetine was the reference drug. To check whether the tryptophan content in the soy bean diet was effective, a group of animals was injected with a single dose of tryptophan on the test day. Results: IFN-α increased the immobility time in the FST (192 sec ± 5.4), that denotes depression in mice. Soybean diets caused less immobility that was more profound with 50% soybean (26.4 sec ± 6). This diet overcame the depression caused by IFN in the FST (54 sec±18). This result was parallel with that of tryptophan injected to animals (38 sec±17). All the animals showed normal locomotor activity. Conclusion: For the first time, we showed that soybean diet could counteract with depression caused by IFN-α. Since tryptophan therapy had similar effects, possibly the tryptophan content of soybean had induced the serotonin synthesis. Thus, not only less harmful kynurenine was produced but also more serotonin was available in the brain to overcome depression. However, this interpretation needs further evaluations.

Authors

Yazdan Azimi Fashi

Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical sciences, Isfahan university of Medical Sciences, Isfahan, Iran

Azadeh Mesripour

Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical sciences, Isfahan university of Medical Sciences, Isfahan, Iran

Valiollah Hajhashemi

Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical sciences, Isfahan university of Medical Sciences, Isfahan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Bale TL, Vale WW. 2003. Increased depression-like behaviors in corticotropin-releasing ...
  • Banaszkiewicz T. 2011. Nutritional value of soybean meal. In: El-Shemy ...
  • Baranyi A, Meinitzer A, Breitenecker RJ, Amouzadeh-Ghadikolai O, Stauber R, ...
  • Baranyi A, Meinitzer A, Stepan A, Putz-Bankuti C, Breitenecker RJ, ...
  • Bonaccorso S,  Marino V,  Puzella A, Pasquini M, Biondi M, ...
  • Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, ...
  • Capuron L, Ravaud A, Neveu P, Miller A, Maes M, ...
  • Castagné V, Porsolt RD, Moser P. 2009. Use of latency ...
  • Cervo L, Canetta A, Calcagno E, Burbassi S, Sacchetti G, ...
  • Chen Y, Guillemin GJ. 2009. Kynurenine pathway metabolites in humans: ...
  • Felger JC, Lotrich FE. 2013. Inflammatory cytokines in depression: neurobiological ...
  • Firk C, Markus CR. 2009. Mood and cortisol responses following ...
  • Fischer CW, Eskelund A, Budac DP, Tillmann S, Liebenberg N,  ...
  • Guillemin G, Brew B, Noonan C, Takikawa O, Cullen K. ...
  • Guillemin GJ, Smith DG, Kerr SJ, Smythe GA, Kapoor V, ...
  • Hemsley KM, Hopwood JJ. 2005. Development of motor deficits in ...
  • Heyes MP, Eugene O, Saito K. 1997. Different kynurenine pathway ...
  • Heine W, Radke M, Wutzke KD. 1995. The significance of ...
  • Kraus MR, Schäfer A, Al‐Taie O, Scheurlen M. 2005. Prophylactic ...
  • Kulkarni SK, Dhir A. 2007. Effect of various classes of ...
  • Laugeray A, Launay J-M, Callebert J, Surget A, Belzung C, ...
  • Lotrich FE, Albusaysi S, Ferrell RE. 2013. Brain-derived neurotrophic factor ...
  • Makino M, Kitano Y, Komiyama C, Takasuna K. 2000. Human ...
  • Moore P, Landolt H-P, Seifritz E, Clark C, Bhatti T, ...
  • Moreno FA, Heninger GR, McGahuey CA, Delgado PL. 2000. Tryptophan ...
  • Owens MJ, Nemeroff CB. 1994. Role of serotonin in the ...
  • Parsons C, Hashimoto K, Wedekind K, Han Y, Baker D. ...
  • Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, ...
  • Ping F, Shang J, Zhou J, Zhang H, Zhang L. ...
  • Ressler KJ, Nemeroff CB. 2000. Role of serotonergic and noradrenergic ...
  • Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, ...
  • Sammut S, Goodall G, Muscat R. 2001. Acute interferon-α administration ...
  • Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, ...
  • Tavakkoli-Kakhki M, Eslami S, Motavasselian M. 2015. Nutrient-rich versus nutrient-poor ...
  • Wichers M, Koek G, Robaeys G, Verkerk R, Scharpe S, ...
  • Yu S, Guo X, Yang H, Zheng L, Sun Y. ...
  • نمایش کامل مراجع